Patents

Nature of the Patent System

A patent is a statutory grant that gives the patentee, for a limited period, the exclusive right to prevent others from commercially exploiting the patented invention in the Philippines. It is not a natural right, a reward for effort alone, or a permit to practice the invention; it is a legally defined exclusionary right given in exchange for an enabling public disclosure.

The patent system rests on a bargain. The inventor discloses a technical solution with enough clarity for a person skilled in the art to carry it out, and the State gives a temporary monopoly over the claimed invention. After the patent expires, the invention falls into the public domain and may be freely used by anyone, subject to other applicable laws.

Patent rights are territorial. A Philippine patent generally has effect only within Philippine territory, and a foreign patent does not by itself give enforceable exclusionary rights in the Philippines. Conversely, a Philippine patent does not control acts done wholly abroad, although importation into the Philippines may fall within the patentee's exclusive rights.

The subject of a patent is an invention, meaning a technical solution to a problem in any field of human activity. It may be, or may relate to, a product, a process, or an improvement of either. The protected matter is not the inventor's broad idea, commercial objective, or scientific insight in the abstract, but the claimed technical teaching that meets the statutory requirements.

The claims define the metes and bounds of the patent monopoly. The specification and drawings may explain the claims and supply context, but the patentee cannot enforce an unclaimed contribution as though it were claimed. A strong patent disclosure therefore performs two functions at the same time: it teaches the public how to carry out the invention and identifies the precise territory from which competitors are excluded.

Patentability

Patentability requires more than usefulness. An invention must be new, involve an inventive step, and be industrially applicable. These requirements filter out subject matter already available to the public, routine developments that do not deserve a monopoly, and ideas that cannot be practically applied in industry.

Prior art consists of everything made available to the public anywhere in the world before the filing date or valid priority date, whether by written description, oral disclosure, use, sale, or other means. The focus is public availability, not whether the applicant actually knew of the earlier disclosure.

Novelty is destroyed when a single prior art reference discloses every material element of the claimed invention, expressly or inherently. Inventive step is a different inquiry: even if no single earlier disclosure anticipates the claim, the claim may still be unpatentable if the advance would have been obvious to the skilled person from the prior art as a whole.

The person skilled in the art is a legal construct, not a genius and not a layperson. This notional person has ordinary competence in the relevant technical field, knows the common general knowledge, and can perform routine experimentation, but does not exercise inventive faculty.

Industrial applicability is usually a low threshold. It is satisfied when the invention can be made or used in any kind of industry, including agriculture, manufacturing, commerce, and technology-based services. The invention need not be commercially successful, cheaper than existing products, or already reduced to mass production.

Some subject matter is excluded because it is not the kind of technical invention protected by patent law, or because public policy withholds patent protection. Discoveries, scientific theories, mathematical methods, aesthetic creations, schemes or rules for mental acts, games or business methods, and computer programs as such are not patentable merely by being described in technical language.

For drugs and medicines, the Cheaper Medicines Act narrowed patentable subject matter by excluding mere discoveries of a new form or new property of a known substance, mere new uses of known substances, and mere use of known processes, unless the statutory conditions for genuine technical contribution are met. The rule prevents patent extension through minor changes that do not amount to a real pharmaceutical invention.

Methods for treatment of the human or animal body by surgery or therapy, and diagnostic methods practiced on the human or animal body, are excluded to keep medical practice free from private monopolies. This exclusion does not automatically bar patents on products, substances, compositions, apparatus, or technical tools used in diagnosis or treatment, if they independently satisfy patentability requirements.

Plant varieties, animal breeds, and essentially biological processes for producing plants or animals are generally outside patent protection, except for microorganisms and non-biological or microbiological processes. Inventions whose exploitation is contrary to public order or morality are likewise excluded, because the patent system does not compel the State to reward harmful technical applications.

Application, Priority, and Grant

The Philippine patent system follows the first-to-file principle. As between persons who independently make the same invention, the right to the patent generally belongs to the person who first files a valid application, subject to rules on priority and remedies of the person truly entitled to the invention.

A patent application is filed with the Intellectual Property Office of the Philippines. It ordinarily contains a request for grant, a description of the invention, one or more claims, drawings when necessary, and an abstract. The description teaches the invention; the claims define the legal monopoly; the abstract serves technical information purposes and does not control the scope of protection.

The filing date is crucial because it anchors novelty, inventive step, priority, and the term of protection. A valid filing date generally requires documents that identify the applicant, indicate that a patent is sought, and disclose the invention sufficiently to be treated as an application.

A Philippine applicant may claim priority from an earlier foreign application filed in a convention country if the Philippine application is filed within the allowed priority period and the formal requirements are complied with. A valid priority claim allows the later Philippine application to be treated, for prior art purposes, as if filed on the earlier priority date for the same invention.

Patent applications are examined to determine whether the claimed invention meets the statutory conditions. The applicant may be required to amend, clarify, restrict, or defend the claims. Amendments cannot add new matter beyond the original disclosure, because the applicant may not enlarge the technical teaching after seeing the prior art or the market.

A granted patent is published and recorded, giving public notice of the claims that may be enforced. The patent term is twenty years from the filing date of the application, subject to payment of required fees and other conditions for maintaining the patent. Once the term ends, the patentee's exclusive rights cease by operation of law.

Entitlement and Ownership

The right to a patent belongs to the inventor, the inventor's heirs, or assigns. If two or more persons jointly made the invention, the right belongs to them jointly, unless their agreement or applicable law provides otherwise. Joint inventorship requires contribution to the inventive concept, not merely financing, supervision, testing, or following instructions.

If two or more persons independently make the same invention, the right to the patent belongs to the person who first filed the application or validly claimed the earliest priority. The first-to-file rule allocates patent rights efficiently, but it does not protect a filer who derived the invention from the true inventor through fraud, breach of confidence, or other wrongful taking.

In commissioned work, the person who commissioned the work owns the patent unless there is a contrary agreement. In employment, an employee generally owns an invention made outside regular duties even if employer resources are used, while the employer owns an invention resulting from the employee's regularly assigned duties, unless an agreement provides otherwise.

Ownership of the patent is distinct from ownership of the physical thing embodying the invention. A buyer of a patented machine owns that particular machine, but does not thereby receive the right to manufacture additional machines if that act remains within the patent monopoly. Likewise, a shareholder, lender, or manager does not become an inventor merely because the invention benefits the business.

If an application is filed by a person not entitled to the patent, the person with the better right may seek appropriate relief before grant, including recognition of entitlement or transfer of the application. If the patent has already been granted to one who is not entitled, the true and actual inventor or other rightful owner may seek substitution, cancellation, or damages within the period allowed by law.

Rights Conferred by a Patent

The core patent right is the right to exclude. For a patented product, the patentee may prevent others from making, using, offering for sale, selling, or importing the patented product without authority. For a patented process, the patentee may prevent others from using the process and from dealing in a product directly obtained by that process.

Because the right is exclusionary, a patent does not guarantee freedom to operate. A patented improvement may still infringe an earlier broader patent, a patented drug may still require regulatory approval before sale, and a patented device may still be subject to safety, health, competition, customs, or environmental laws.

The patentee may exploit the invention personally, assign the patent, license another to use it, mortgage or encumber it, or transmit it by succession or other lawful mode. Patent rights are property rights, but they remain limited by the claims, the term, territoriality, statutory exceptions, competition policy, and public interest limitations.

Patent protection covers the invention as claimed, not every product in the same field or every solution to the same problem. Competitors remain free to design around the claims, use public domain technology, rely on expired patents, practice non-infringing alternatives, and challenge invalid claims.

Limitations on Patent Rights

Patent law balances exclusivity with access, competition, and public welfare. The patentee's rights do not extend to every contact with the invention, and several uses are outside the monopoly even during the patent term.

• Private and non-commercial use. Acts done privately and on a non-commercial scale do not ordinarily implicate the commercial monopoly protected by the patent.
• Experimental use. Use of the patented invention for experiments relating to the subject matter of the invention may be allowed because technical inquiry should not be frozen by the patent grant.
• Regulatory testing. Acts necessary to obtain regulatory approval for drugs and medicines may be permitted before patent expiry, so that lawful market entry can occur without undue delay after expiry.
• Individual pharmacy preparation. Preparation of a medicine for an individual case under a medical prescription may fall outside the patentee's general commercial control.
• Prior user rights. A person who, in good faith, was already using the invention or had made serious preparations to use it before the filing or priority date may continue that use within the allowed scope.
• Temporary presence of foreign conveyances. Use of the patented invention in foreign vessels, aircraft, or land vehicles temporarily or accidentally entering Philippine territory may be exempt when confined to the needs of the conveyance.
• Exhaustion. Once a patented product has been placed on the market by the patentee or with the patentee's consent, the patentee's control over that particular item is generally exhausted.
• Government use and compulsory licensing. Public interest, national emergency, public non-commercial use, anti-competitive conduct, non-working, or dependency between patents may justify use without the patentee's voluntary consent, subject to statutory safeguards and remuneration.

Exhaustion is especially significant in trade involving medicines. The law permits parallel importation of patented drugs under the conditions fixed by statute, reflecting the policy that patent rights should not be used to block access to more affordable legitimate medicines already placed in commerce.

Compulsory licensing does not cancel the patent. It authorizes another person to work the invention without the patentee's voluntary license, usually on non-exclusive terms and with compensation. The patent remains valid, but the patentee's power to refuse all use yields to the statutory ground for intervention.

Infringement

Patent infringement occurs when a person, without authority, performs acts reserved to the patentee with respect to the patented invention. The comparison is between the accused product or process and the patent claims, read in light of the specification and the ordinary understanding of the relevant technical field.

Literal infringement exists when every element of a claim is found in the accused product or process. If a material element is absent, there is generally no literal infringement of that claim, although infringement may still be considered under equivalent principles when the accused substitute appropriates the patented technical teaching in substance.

The doctrine of equivalents prevents a copyist from escaping liability through insubstantial changes. A substituted element may be treated as equivalent when it performs substantially the same function, in substantially the same way, to achieve substantially the same result, and when treating it as equivalent does not improperly expand the claim beyond what the patentee disclosed and claimed.

Contributory infringement reaches a person who knowingly supplies or induces the use of a component especially adapted for infringing the patented invention and not suitable for substantial non-infringing use. The doctrine targets participation in infringement without requiring the contributor personally to perform every infringing act.

In process patents, proof problems may arise because the infringing process is often performed inside the defendant's facility. Where the law creates a presumption regarding products obtained by a patented process, the defendant may be required to show that the identical product was made by a different process, while legitimate manufacturing secrets are protected as far as practicable.

Available civil relief may include injunction, damages, attorney's fees in proper cases, and disposition or destruction of infringing goods and implements. Damages may reflect actual loss, the infringer's gain, reasonable royalty, or other legally accepted measures, subject to proof and the court's equitable discretion.

Invalidity may be raised as a defense in an infringement action. If the asserted claim is not patentable, lacks sufficient disclosure, or is otherwise legally defective, the defendant should not be made to pay for practicing subject matter that the patentee had no right to monopolize.

Criminal liability is exceptional and statutory. It is associated with repetition of infringement after a final judgment of infringement and is subject to the elements, penalties, and prescriptive rules fixed by law. The ordinary enforcement path for first infringement is civil.

Cancellation and Loss of Patent Effect

A granted patent is presumed valid in the practical sense that it may be enforced until set aside, but the grant is not conclusive against the world. Any interested person may seek cancellation when the claimed invention is not patentable, the patent does not disclose the invention clearly and completely enough for skilled performance, or the patent is contrary to public order or morality.

Cancellation may be total or partial. If only some claims are invalid, the remaining valid claims may survive, provided they can stand independently and the scope of monopoly is clear. Partial cancellation reflects the claim-by-claim nature of patent protection.

The effect of cancellation is to remove the legal foundation for the cancelled claims. A person cannot infringe a claim that the law treats as void, and the public is not bound to respect a monopoly that should not have been granted. Separate issues may remain concerning final judgments, accrued liabilities, good faith, and procedural consequences.

Patent rights may also end or lose practical enforceability through expiry of the term, failure to pay required maintenance fees, surrender, or successful assertion of defenses in enforcement proceedings. These outcomes differ from cancellation, but each limits the patentee's ability to exclude others.

Licensing, Assignment, and Transfer

A patent license permits another person to do acts that would otherwise infringe the patent. It may be exclusive, non-exclusive, sole, limited by territory, limited by field of use, limited by duration, or conditioned on royalties and performance obligations. The license does not transfer ownership unless the agreement shows an assignment.

Voluntary licensing is generally allowed, but technology transfer arrangements are subject to statutory controls. Clauses that unduly restrain trade, suppress competition, require payment for unused patents, prohibit challenges to validity, or impose abusive grant-back and procurement restrictions may be prohibited. Mandatory clauses protect access to improvements, confidentiality within lawful limits, governing law, and continued availability of remedies.

An assignment transfers ownership of the patent or of an undivided share in it. Because a patent is an intangible property right created by statute, assignments and other transmissions should be in writing and recorded when recordation is required to affect third persons. Between the parties, their contract controls their rights, but against strangers and later transferees, registration and notice rules become important.

Patent rights may also pass by succession, merger, corporate reorganization, execution, or other modes recognized by law. The transferee takes the patent subject to its existing limitations, including prior licenses, compulsory licenses, statutory exceptions, remaining term, unpaid maintenance obligations, and vulnerability to cancellation.

A licensee's ability to sue depends on the nature of the license and the governing agreement. An exclusive licensee may have a direct economic stake in enforcement, while a non-exclusive licensee ordinarily relies on the patentee unless the contract or procedural rules allow participation. In all cases, enforcement must remain anchored on the patent claims and the rights actually granted.

Relationship with Public Interest and Competition

Patent law protects innovation without treating monopoly as an end in itself. The exclusive right is justified only within the boundaries of the disclosed and claimed invention, for the statutory term, and subject to limitations that preserve health, competition, research, and access to technology.

The public interest is particularly visible in pharmaceutical patents. The law recognizes genuine drug innovation while preventing practices that delay generic competition through weak secondary patents, unjustified refusal to license, abusive pricing structures tied to monopoly power, or barriers to lawful parallel importation and regulatory preparation.

Competition law and patent law are complementary. A patent may lawfully exclude competitors from the claimed invention, but it does not authorize sham enforcement, anti-competitive tying, market allocation, price fixing, bad-faith accumulation of blocking rights, or license terms that extend control beyond the patent grant.

The central organizing principle is proportionality between disclosure and exclusivity. The inventor receives protection only for what is new, inventive, industrially applicable, sufficiently disclosed, and properly claimed; the public receives technical knowledge, eventual free access, and continued freedom to use everything outside the patent.